Revealing the potential of DNA-based vaccination: Lessons learned from the hepatitis B virus surface antigen

Biological Chemistry

Volumn 382, Issue 4, 2001, Pages 543-552

  Schirmbeck, Reinhold ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Antibody responses; CD8+ cytotoxic T lymphocytes; DNA based vaccines; Expression vectors; Hepatitis B virus

Indexed keywords

ANTIGEN; CD8 ANTIGEN; DNA; DNA VACCINE; EPITOPE; HEPATITIS B SURFACE ANTIGEN; PEPTIDE; PLASMID DNA; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN EXPRESSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; GENE TARGETING; GENETIC TRANSFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENICITY; PLASMID; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; VACCINATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INJECTIONS, INTRAMUSCULAR; MUSCLES; PLASMIDS; SKIN; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

ANIMALIA; HEPATITIS B VIRUS;

EID: 0035008047     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2001.068     Document Type: Review

References (72)

1. + T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7, 791-802.
2. Boczkowski, D., Nair, S.K., Snyder, D., and Gilboa, E. (1996). Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184, 465-472.
3. Boyer, J., Ugen, K., Wang, B., Chattergoon, M., Tsai, A., Merva, M., and Weiner, D.B. (1998). Induction of a TH1 type cellular immune response to the human immunodeficiency type 1 virus by in vivo DNA inoculation. Dev. Biol. Stand. 92, 169-174.
4. Boyle, J.S., Koniaras, C., and Lew, A.M. (1997). Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol. 9, 1897-1906.
5. Böhm, W., Kuhröber, A., Paier, T., Mertens, T., Reimann, J., and Schirmbeck, R. (1996). DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocytes and antibody responses in mice after intramuscular injection. J. Immunol. Methods 193, 29-40.
6. Böhm, W., Mertens, T., Schirmbeck, R., and Reimann, J. (1998). Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 16, 949-954.
7. Chen, C.H., Ji, H., Suh, K.W., Choti, M.A., Pardoll, D.M., and Wu, T.C. (1999). Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs. Gene Ther. 6, 1972-1981.
8. Chow, Y.H., Chiang, B.L., Lee, Y.L., Chi, W.K., Lin, W.C., Chen, Y.T., and Tao, M.H. (1998). Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160, 1320-1329.
9. Chow, Y.H., Huang, W.L., Chi, W.K., Chu, Y.D., and Tao, M.H. (1997). Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71, 169-178.
10. Conry, R.M., LoBuglio, A.F., Wright, M., Sumerel, L., Pike, M.J., Johanning, F., Benjamin, R.J., Lu, D., and Curiel, D.T. (1995). Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res. 55, 1397-1400.
11. Davis, H.L., Michel, M.-L., and Whalen, R.G. (1993). DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2, 1847-1851.
12. Davis, H.L., Michel, M.-L., Mancini, M., Schleef, M., and Whalen, R.G. (1994). Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 12, 1503-1509.
13. Davis, H.L., Schirmbeck, R., Reimann, J., and Whalen, R.G. (1995). DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to Hepatitis B virus surface antigen. Hum. Gene Ther. 6, 1447-1456.
14. Davis, H.L., Mancini, M., Michel, M.-L., and Whalen, R.G. (1996). DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14, 910-915.
15. Deck, R.R., DeWitt, C.M., Donnelly, J.J., Liu, M.A., and Ulmer, J.B. (1997). Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine 15, 71-78.
16. + T cell immunogenicity and protective efficacy in the influenza and malaria models. Vaccine 18, 623-632.
17. Donnelly, J.J., Ulmer, J.B., Shiver, J.W., and Liu, M.A. (1997). DNA vaccines. Annu. Rev. Immunol. 15, 617-648.
18. Ertl, H.C. and Xiang, Z. (1996). Novel vaccine approaches. J. Immunol. 156, 3579-3582.
19. Feltquate, D.M., Heaney, S., Webster, R.G., and Robinson, H.L. (1997). Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158, 2278-2284.
20. Fuller, D.H., Murphey, C.M., Clements, J., Barnett, S., and Haynes, J.R. (1996). Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J. Med. Primatol. 25, 236-241.
21. Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C., and Robinson, H.L. (1993). DNA Vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90, 11478-11482.
22. Geissler, M., Tokushige, K., Chante, C.C., Zurawski-VR, J., and Wands, J.R. (1997). Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology 112, 1307-1320.
23. Geissler, M., Schirmbeck, R., Reimann, J., Blum, H.E., and Wands, J.R. (1998). Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice. Hepatology 28, 202-210.
24. Gurunathan, S., Klinman, D.M., and Seder, R.A. (2000). DNA vaccines: immunology, application and optimization. Annu. Rev. Immunol. 18, 927-974.
25. Haddad, D., Liljeqvist, S., Stahl, S., Andersson, I., Perlmann, P., Berzins, K., and Ahlborg, N. (1997). Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice. FEMS Immunol. Med. Microbiol. 18, 193-202.
26. He, X.S., Chen, H.S., Chu, K., Rivkina, M., and Robinson, W.S. (1996). Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 93, 7274-7278.
27. Heermann, K.-H. and Gerlich, W.H.(1991). In: The molecular biology of hepatitis B virus, A. McLachlan, ed, (Boca Raton, USA: CRC Press), pp. 109-132.
28. Hoerr, I., Obst, R., Rammensee, H.G., and Jung, G. (2000). In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur. J. Immunol. 30, 1-7.
29. Inchauspe, G., Vitvitski, L., Major, M.E., Jung, G., Spengler, U., Maisonnas, M., and Trepo, C. (1997). Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16, 185-195.
30. Ishikawa, T., Kono, D.H., Fowler, P., Theofilopoulos, A.N., Kakumu, S., and Chisari, F.V. (1998). Polyclonality and multispecificity of the CTL response to a single viral epitope. J. Immunol. 161, 5842-5850.
31. Johnston, S.A. and Tang, D.C. (1994). Gene gun transfection of animal cells and genetic immunization. Methods Cell Biol. 43, 353-365.
32. Justewicz, D.M., Morin, M.J., Robinson, H.L., and Webster, R.G. (1995). Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin. J. Virol. 69, 7712-7717.
33. Koprowski, H. and Weiner, D.B. (1998). DNA vaccination/genetic vaccination. Curr. Top. Microbiol. Immunol. 226, 5-13.
34. Kwissa, M., von Kampen, J., Zurbriggen, R., Glueck, R., Reimann, J., and Schirmbeck, R. (2000a). Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control. Vaccine 18, 2337-2344.
35. Kwissa, M., Unsinger, J., Schirmbeck, R., Hauser, H., and Reimann, J. (2000b). Polyvalent DNA vaccines with bidirectional promoters. J. Mol. Med. 78, 495-506.
36. Le, S.J., Chouteau, P., Cannie, I., Guguen, G.C., and Gripon, P. (1998). Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J. Virol. 72, 5573-5578.
37. Leitner, W.W., Seguin, M.C., Ballou, W.R., Seitz, J.P., Schultz, A.M., Sheehy, M.J., and Lyon, J.A. (1997). Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159, 6112-6119.
38. Levitsky, H.I. (1997). Accessories for naked DNA vaccines. Nature Biotechnol. 15, 619-620.
39. Mahvi, D.M., Burkholder, J.K., Turner, J., Culp, J., Malter, J.S., Sondel, P.M., and Yang, N.S. (1996). Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. Hum. Gene Ther. 7, 1535-1543.
40. Mahvi, D.M., Sheehy, M.J., and Yang, N.S. (1997). DNA cancer vaccines: a gene gun approach. Immunol. Cell Biol. 75, 456-460.
41. Mancini, M., Davis, H.L., Tiollais, P., and Michel, M.-L. (1996). DNA-based immunization against the envelope proteins of the hepatitis B virus. J. Biotechnol. 44, 47-57.
42. Martinon, F., Krishnan, S., Lenzen, G., Magné, R., Gomard, E., Guillet, J.-G., Lévy, J.-R, and Meulien, R (1993). Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 23, 1719-1722.
43. McCarthy, M. (1996). DNA vaccination: a direct line to the immune system. Lancet 348, 1232-1232.
44. McDonnell, W.M. and Askari, F.K. (1996). DNA vaccines. N. Engl. J. Med. 334, 42-45.
45. Michel, M.-L., Davis, H.L., Schleef, M., Mancini, M., Tiollais, P., and Whalen, R.G. (1995). DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA 92, 5307-5311.
46. Montgomery, D.L., Shiver, J.W., Leander, K.R., Perry, H.C., Friedman, A., Martinez, D., Ulmer, J.B., Donnelly, J.J., and Liu, M.A. (1993). Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12, 777-783.
47. Pertmer, T.M., Eisenbraun, M.D., McCabe, D., Prayaga, S.K., Fuller, D.H., and Haynes, J.R. (1995). Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13, 1427-1430.
48. + T cells after gene gun immunization. J. Exp. Med. 188, 1075-1082.
49. Prange, R., Werr, M., Birkner, M., Hilfrich, R., and Streeck, R.E. (1995). Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes. J. Gen. Virol. 76, 2131-2140.
50. Qiu, P., Ziegelhoffer, P., Sun, J., and Yang, N.S. (1996). Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther. 3, 262-268.
51. Raz, E., Carson, D.A., Parker, S.E., Parr, T.B., Abai, A.M., Aichinger, G., Gromkowski, S.H., Singh, M., Lew, D., Yankauckas, M.A., and et al (1994). Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 97, 9519-9523.
52. Reimann, J. and Schirmbeck, R. (1999). Alternative processing pathways for exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation. Immunol. Rev. 171, 131-152.
53. d molecules capture peptides from endocytosed, exogenous antigens for MHC class I-restricted presentation. Eur. J. Immunol. 26, 2812-2821.
54. + cytotoxic T lymphocyte responses in vivo. J. Immunol. 152, 1110-1119.
55. Schirmbeck, R., Böhm, W., Ando, K.-I., Chisari, F.V., and Reimann, J. (1995a). Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69, 5929-5934.
56. Schirmbeck, R., Melber, K., and Reimann, J. (1995b). Hepatitis B virus surface particles are processed in a novel endosomal pathway for MHC class I-restricted epitope presentation. Eur. J. Immunol. 25, 1063-1070.
57. Schirmbeck, R., Böhm, W., Melber, K., and Reimann, J. (1995c). Processing of exogenous heat-aggregated (denatured) or particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J. Immunol. 155, 4676-4684.
58. d-restricted epitope presentation depends on exogenous β2m. Eur. J. Immunol. 27, 3471-3484.
59. Schirmbeck, R., Wild, J., and Reimann, J. (1998). Similar as well as distinct MHC-I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen (HBsAg). Eur. J. Immunol. 28, 4149-4161.
60. Schirmbeck, R., Wild, J., Stober, D., Blum, H.E., Chisari, F.V., Geissler, M.,and Reimann, J. (2000). Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen. J. Immunol. 164, 4235-4243.
61. Shouval, D., Ilan, Y., Adler, R., Deepen, R., Panet, A., Even, C.Z., Gorecki, M., and Gerlich, W.H. (1994). Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines. Vaccine 12, 1453-1459.
62. Simon, M.M., Gern, L., Hauser, P., Zhong, W., Nielsen, P.J., Kramer, M.D., Brenner, C., and Wallich, R. (1996). Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Eur. J. Immunol. 26, 2831-2840.
63. Sun, W.H., Burkholder, J.K., Sun, J., Culp, J., Turner, J., Lu, X.G., Pugh, T.D., Ershler, W.B., and Yang, N.S. (1995). In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Natl. Acad. Sci. USA92, 2889-2893.
64. Tang, D.C., DeVit, M., and Johnston, S.A. (1992). Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154.
65. Triyatni, M., Jilbert, A.R., Qiao, M., Miller, D.S., and Burrell, C.J. (1998). Protective efficacy of DNA vaccines against duck hepatitis B virus infection. J. Virol. 72, 84-94.
66. Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Feigner, P.L., Dwarki, V.J., Gromkowski, S.H., Deck, R.R., DeWitt, C.M., Friedman, A., and et al (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
67. Ulmer, J.B., Sadoff, J.C., and Liu, M.A. (1996). DNA vaccines. Curr. Opin. Immunol. 8, 531-536.
68. Vahlsing, H.L., Yankauckas, M.A., Sawdey, M., Gromkowski, S.H., and Manthorpe, M. (1994). Immunization with plasmid DNA using a pneumatic gun. J. Immunol. Methods 175, 11-22.
69. Williams, R.S., Johnston, S.A., Riedy, M., DeVit, M.J., McElligott, S.G., and Sanford, J.C. (1991). Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc. Natl. Acad. Sci. USA 88, 2726-2730.
70. Xu, Z., Bruss, V., and Yen, T.S. (1997). Formation of intracellular particles by hepatitis B virus large surface protein. J. Virol. 71, 5487-5494.
71. Yamazaki, H., Tanaka, M., Nagoya, M., Fujimaki, H., Sato, K., Yago, T., Nagata, T., and Minami, M. (1997). Epitope selection in major histocompatibility complex class I-mediated pathway is affected by the intracellular localization of an antigen. Eur. J. Immunol. 27, 347-353.
72. Zarozinski, C.C., Fynan, E.F., Selin, L.K., Robinson, H.L., and Welsh, R.M. (1995). Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154, 4010-4017.